REQUEST A DEMO
Total
USD $0.00
Search more companies

Sit-Med R. Slezak sp. k. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Pharmacies and Drug Stores | Department Stores | Other Miscellaneous Store Retailers | Couriers and Express Delivery Services | Ambulatory Health Care Services | Offices of Physicians | Offices of All Other Miscellaneous Health Practitioners | All Other Miscellaneous Ambulatory Health Care Services | Fitness and Recreational Sports Centers
Full name: Sit-Med R. Slezak sp. k. Profile Updated: June 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Sit-Med R. Slezak sp. k. is a company in Poland, with a head office in Gorzkowice. The company operates in the General Medical and Surgical Hospitals sector. It was incorporated on July 01, 2020. From the latest financial highlights, Sit-Med R. Slezak sp. k. reported a net sales revenue increase of 17.46% in 2025. There was a total negative growth of 10.04% in Sit-Med R. Slezak sp. k.’s total assets over the same period. The net profit margin of Sit-Med R. Slezak sp. k. increased by 1.78% in 2025.

Headquarters
Ul. Kwiatowa 4
Gorzkowice; Lodzkie; Postal Code: 97-350

Contact Details: Purchase the Sit-Med R. Slezak sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Sit-Med R. Slezak sp. k. report to view the information.
Incorporation Date:
July 01, 2020
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Sit-Med R. Slezak sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
17.46%
Total Operating Revenue
25.17%
Operating Profit
29.65%
EBITDA
25.56%
Net Profit/Loss for the Period
29.71%
Total Assets
-10.04%
Total Equity
-13.72%
Operating Profit Margin
1.96%
Net Profit Margin
1.78%
Return on Equity (ROE)
28.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?